Hot or Not, Stock Market Edition: 06/24/2025

Here’s what’s making moves in the market today: 

• HOT: Hims & Hers Health (HIMS) has gained over 160% in the past few months; APi Group’s (APG) enjoys a slow, steady climb
• NOT: Despite good news, Apple (AAPL) still has a “Hold” rating according to our quant ratings system; Smith & Wesson Brands (SWBI) takes a nosedive

P.S. For more stocks making moves, check out our new Zen Ratings Upgrades & Downgrades screener.

A note from our sponsors...
Sleep well at night with 7 stellar stocks to buy and hold forever
  

Every powerhouse name on this list is already a proven winner. You won't find any risky moonshots, startups, or unicorns. Just best-in-class blue chips you can hold for years to come.  

Get the complete list FREE for a limited time.

🔥 HOT: APi Group’s (NYSE: APG) slow and steady climb over the last six months has earned it an A rating in Safety and an overall Zen Rating of B. The stock jumped by 4.7% on Friday after the announcement that it would be replacing U.S. Steel on the S&P 400 mid-cap index after the latter company was acquired by Japan’s Nippon Steel Corp. APG is now up 41.6% YTD and comes with a Buy recommendation.

🥶 NOT: Apple (NASDAQ: AAPL) finally got some good news on Friday after a decision was made that the company would not face immediate repercussions from its shirking of the European Union’s Digital Markets Act. The stock gained 2.2% by the closing bell, but that’s not enough to erase the rocky year it's had so far. AAPL is down 19.3% YTD after an atrocious March and April, and the stock hasn’t recovered as much as the rest of tech after the tariff pause at the beginning of April. AAPL is on our radar as a potential buy if policies shift in its favor, but for now, we give it a C Zen Rating and a Hold recommendation.

🔥 HOT: Shares of Hims & Hers Health (NYSE: HIMS) have gained 168.0% in the last two and a half months after gaining an additional 5.2% on Friday. Buying now might seem like a bad idea, but our research suggests that’s precisely the right move to make. Our analysis gives HIMS A ratings in Financials and Growth, which means a strong foundation and high potential for gains in the near and mid terms. The company’s recent acquisition of ZAVA, which will help it expand its business in Europe, paves the way for some big numbers, but it's unclear what impact it will have by its next earnings report in August. The bottom line is that we give HIMS a B Zen Rating and a Buy recommendation.

🥶 NOT: Smith & Wesson Brands (NASDAQ: SWBI) took a nosedive on Friday, losing 19.8% after a gut punch of an earnings report. The company missed its EPS projection and revenue estimate by 13.0% and 7.6%, respectively, citing declining sales due to the extreme sales spike of the pandemic era. The company is also dealing with a potential lawsuit from Mexico that claims the company was involved in illegal trafficking of its guns to cartels. The company’s Growth rating is an atrocious F, and its D Sentiment rating isn’t much better. We give SWBI a Sell recommendation and a D Zen Rating.

What to Do Next?

• 9 Special Stock Lists You Need Now >
• See All “A” Rated Stocks with +32.52% Average Annual Return >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.